ROBERT MELVILLE SWENSON, M.D.
Osteopathic Medicine at Mount Airy Ave, Philadelphia, PA
License number
Pennsylvania MD0011131E
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Pennsylvania MD011131E
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
600 W Mount Airy Ave, Philadelphia, PA 19119
Phone
(215) 247-5530
Personal information
See more information about ROBERT MELVILLE SWENSON at radaris.comName
Address
Phone
600 W Mount Airy Ave, Philadelphia, PA 19119
46 N Edgewater Ave, Yardley, PA 19067
4384 S Woodland Dr, Bensalem, PA 19020
Professional information
Dr. Robert M Swenson, Philadelphia PA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
600 W Mount Airy Ave, Philadelphia 19119
(215) 247-5530 (Phone)
(215) 247-5530 (Phone)
Certifications:
Infectious Disease, 1974, Internal Medicine, 1974
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Washington Center / School of Medicine
Barnes-Jewish Hospital
Univ Texas S
Washington Center / School of Medicine
Barnes-Jewish Hospital
Univ Texas S
Independent Hospital &Amp; Health Care Professional
Location:
Greater Philadelphia Area
Industry:
Hospital & Health Care
Group B Streptococcus Antigens And Vaccines
US Patent:
4439422, Mar 27, 1984
Filed:
Feb 2, 1982
Appl. No.:
6/345054
Inventors:
Robert M. Swenson - Philadelphia PA
Gerald D. Shockman - Philadelphia PA
Toby K. Eisenstein - Wyndmoor PA
Roberta B. Carey - Princeton Junction NJ
Gerald D. Shockman - Philadelphia PA
Toby K. Eisenstein - Wyndmoor PA
Roberta B. Carey - Princeton Junction NJ
Assignee:
Research Corporation - New York NY
International Classification:
A61K 3902, C08B 3700, C12P 1904
US Classification:
424 92
Abstract:
Pure Group B Streptococcus antigen and Group B, Type III Streptococcus antigen are isolated, separated and purified from the culture medium in which the Group B, Type III Streptococcus are grown. The process involves (a) culturing the Group B, Type III Streptococcus in a nutrient medium, free of animal proteins and lipids, containing from 1 to 5% by weight glucose and from 0. 04 M to 0. 16 M phosphates; (b) separating the bacterial cells from the culture medium; (c) extracting and separating the Group B antigens and the Type III antigens from the culture medium supernatant by means of an anion exchanger; and, (d) purifying the resulting antigenic materials by chromatography on an agarose gel column. The antigens can be used as vaccines against infections caused by Group B or Group B, Type III Streptococcus.